Novo Nordisk Foundation to launch $260M vaccine initiative in early 2024

The No­vo Nordisk Foun­da­tion, which op­er­ates in­de­pen­dent­ly from the phar­ma com­pa­ny, is pump­ing DKK 1.8 bil­lion ($260 mil­lion) to launch an ini­tia­tive de­signed to de­vel­op res­pi­ra­to­ry dis­ease vac­cines.

The No­vo Nordisk Foun­da­tion Ini­tia­tive for Vac­cines and Im­mu­ni­ty (NIVI) will be­gin in the first quar­ter of next year. It will hire up to 200 peo­ple in­ter­nal­ly from the foun­da­tion as well as ex­ter­nal­ly.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.